Wellington Management Group’s Viridian Therapeutics VRDN Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2025
Q2 | $3.78M | Buy |
270,543
+21,373
| +9% | +$299K | ﹤0.01% | 1438 |
|
|
2025
Q1 | $3.36M | Buy |
249,170
+24,686
| +11% | +$333K | ﹤0.01% | 1452 |
|
|
2024
Q4 | $4.3M | Sell |
224,484
-11,503
| -5% | -$221K | ﹤0.01% | 1375 |
|
|
2024
Q3 | $5.37M | Sell |
235,987
-48,057
| -17% | -$1.09M | ﹤0.01% | 1314 |
|
|
2024
Q2 | $3.7M | Buy |
284,044
+43,215
| +18% | +$562K | ﹤0.01% | 1382 |
|
|
2024
Q1 | $4.22M | Buy |
240,829
+48,732
| +25% | +$853K | ﹤0.01% | 1365 |
|
|
2023
Q4 | $4.18M | Sell |
192,097
-23,551
| -11% | -$513K | ﹤0.01% | 1350 |
|
|
2023
Q3 | $3.31M | Buy |
215,648
+43,349
| +25% | +$665K | ﹤0.01% | 1380 |
|
|
2023
Q2 | $4.1M | Buy |
172,299
+47,903
| +39% | +$1.14M | ﹤0.01% | 1325 |
|
|
2023
Q1 | $3.16M | Buy |
124,396
+3,893
| +3% | +$99K | ﹤0.01% | 1394 |
|
|
2022
Q4 | $3.52M | Buy |
+120,503
| New | +$3.52M | ﹤0.01% | 1366 |
|
|
2021
Q3 | – | Sell |
-578,560
| Closed | -$10.6M | – | 2270 |
|
|
2021
Q2 | $10.6M | Hold |
578,560
| – | – | ﹤0.01% | 1253 |
|
|
2021
Q1 | $9.67M | Buy |
+578,560
| New | +$9.67M | ﹤0.01% | 1250 |
|